Teladoc Health (NYSE:TDOC) Shares Gap Up - Should You Buy?

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) shares gapped up before the market opened on Thursday . The stock had previously closed at $9.09, but opened at $9.40. Teladoc Health shares last traded at $9.69, with a volume of 577,934 shares changing hands.

Analysts Set New Price Targets

TDOC has been the topic of a number of recent analyst reports. Royal Bank of Canada raised their price target on shares of Teladoc Health from $9.00 to $10.00 and gave the stock an "outperform" rating in a report on Wednesday, October 9th. Barclays upped their price target on Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a research report on Thursday, October 31st. Jefferies Financial Group lifted their price objective on Teladoc Health from $8.00 to $10.00 and gave the stock a "hold" rating in a research report on Tuesday, September 17th. Deutsche Bank Aktiengesellschaft upped their target price on Teladoc Health from $10.00 to $12.00 and gave the company a "hold" rating in a report on Friday, November 1st. Finally, TD Cowen cut their price target on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, October 31st. Fourteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $12.24.

Teladoc Health Stock Up 4.7 %

The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a fifty day simple moving average of $9.85 and a 200 day simple moving average of $9.05. The firm has a market capitalization of $1.64 billion, a P/E ratio of -1.65 and a beta of 0.97.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, equities analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.95% of the stock is owned by company insiders.

Institutional Trading of Teladoc Health

A number of institutional investors have recently made changes to their positions in the stock. TCW Group Inc. bought a new position in shares of Teladoc Health during the 3rd quarter valued at $2,464,000. Geode Capital Management LLC lifted its holdings in Teladoc Health by 1.5% in the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock valued at $36,042,000 after acquiring an additional 56,864 shares during the period. Y Intercept Hong Kong Ltd purchased a new position in Teladoc Health in the third quarter worth about $152,000. Quantinno Capital Management LP boosted its position in Teladoc Health by 190.4% in the third quarter. Quantinno Capital Management LP now owns 186,143 shares of the health services provider's stock worth $1,709,000 after purchasing an additional 122,050 shares during the last quarter. Finally, Point72 Asset Management L.P. grew its stake in shares of Teladoc Health by 57.8% during the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider's stock valued at $76,803,000 after purchasing an additional 3,063,172 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.